{"id":"https://openalex.org/W4283376564","doi":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","title":"P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)","display_name":"P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)","publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283376564","doi":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000846728.05693.f8","doi":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009378735","display_name":"Saad Z. Usmani","orcid":"https://orcid.org/0000-0002-5484-8731","observed_orcids":["https://orcid.org/0000-0002-5484-8731"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"S. Usmani","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040237587","display_name":"Antje Hoering","orcid":"https://orcid.org/0000-0002-4709-3027","observed_orcids":["https://orcid.org/0000-0002-4709-3027"]},"institutions":[{"id":"https://openalex.org/I4210101190","display_name":"Cancer Research And Biostatistics","ror":"https://ror.org/01575p865","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210101190"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Hoering","raw_affiliation_strings":["Cancer Research And Biostatistics, Seattle"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research And Biostatistics, Seattle","institution_ids":["https://openalex.org/I4210101190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044589378","display_name":"Sikander Ailawadhi","orcid":"https://orcid.org/0000-0002-8377-8111","observed_orcids":["https://orcid.org/0000-0002-8377-8111"]},"institutions":[{"id":"https://openalex.org/I4210146710","display_name":"Mayo Clinic in Florida","ror":"https://ror.org/03zzw1w08","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210146710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Ailawadhi","raw_affiliation_strings":["Mayo Clinic, Jacksonville"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Jacksonville","institution_ids":["https://openalex.org/I4210146710"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Sexton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210101190","display_name":"Cancer Research And Biostatistics","ror":"https://ror.org/01575p865","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210101190"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Sexton","raw_affiliation_strings":["Cancer Research And Biostatistics, Seattle"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Research And Biostatistics, Seattle","institution_ids":["https://openalex.org/I4210101190"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087265191","display_name":"Brea C. Lipe","orcid":"https://orcid.org/0000-0002-7596-2015","observed_orcids":["https://orcid.org/0000-0002-7596-2015"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Lipe","raw_affiliation_strings":["University of Rochester Medical Center, Rochester, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Rochester Medical Center, Rochester, NY","institution_ids":["https://openalex.org/I28792581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072484302","display_name":"Jason Neil Valent","orcid":"https://orcid.org/0000-0001-5605-7020","observed_orcids":["https://orcid.org/0000-0001-5605-7020"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Valent","raw_affiliation_strings":["Cleveland Clinic, Cleveland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cleveland Clinic, Cleveland","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024461673","display_name":"Michael Alan Rosenzweig","orcid":"https://orcid.org/0000-0001-5158-5131","observed_orcids":["https://orcid.org/0000-0001-5158-5131"]},"institutions":[{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Rosenzweig","raw_affiliation_strings":["City of Hope, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope, Los Angeles","institution_ids":["https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078601045","display_name":"Jeff Zonder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210090317","display_name":"The Barbara Ann Karmanos Cancer Institute","ror":"https://ror.org/00ee40h97","country_code":"US","type":"facility","lineage":["https://openalex.org/I2800590384","https://openalex.org/I4210090317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Zonder","raw_affiliation_strings":["Karmanos Cancer Institute, Detroit, MI"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Karmanos Cancer Institute, Detroit, MI","institution_ids":["https://openalex.org/I4210090317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016192618","display_name":"M. Dhodapkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I150468666","display_name":"Emory University","ror":"https://ror.org/03czfpz43","country_code":"US","type":"education","lineage":["https://openalex.org/I150468666"]},{"id":"https://openalex.org/I4390039307","display_name":"Winship Cancer Institute","ror":"https://ror.org/02gars961","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I132943300","https://openalex.org/I150468666","https://openalex.org/I4390039307"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Dhodapkar","raw_affiliation_strings":["Emory Winship Cancer Institute, Atlanta GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Emory Winship Cancer Institute, Atlanta GA","institution_ids":["https://openalex.org/I150468666","https://openalex.org/I4390039307"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042432109","display_name":"Natalie S. Callander","orcid":"https://orcid.org/0000-0002-6975-1086","observed_orcids":["https://orcid.org/0000-0002-6975-1086"]},"institutions":[{"id":"https://openalex.org/I135310074","display_name":"University of Wisconsin\u2013Madison","ror":"https://ror.org/01y2jtd41","country_code":"US","type":"education","lineage":["https://openalex.org/I135310074"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"N. Callander","raw_affiliation_strings":["University of Wisconsin, Madison"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Wisconsin, Madison","institution_ids":["https://openalex.org/I135310074"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089322820","display_name":"T. Zimmerman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210100450","display_name":"BeiGene (China)","ror":"https://ror.org/012v2c923","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210100450"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"T. Zimmerman","raw_affiliation_strings":["Beigene, Chicao"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Beigene, Chicao","institution_ids":["https://openalex.org/I4210100450"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071438752","display_name":"Peter Michael Voorhees","orcid":"https://orcid.org/0000-0003-1661-718X","observed_orcids":["https://orcid.org/0000-0003-1661-718X"]},"institutions":[{"id":"https://openalex.org/I4210100342","display_name":"Levine Cancer Institute","ror":"https://ror.org/0174nh398","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334069289","https://openalex.org/I4210100342"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Voorhees","raw_affiliation_strings":["Levine Cancer Institute, Charlotte"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Levine Cancer Institute, Charlotte","institution_ids":["https://openalex.org/I4210100342"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017112700","display_name":"Brian Durie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1282927834","display_name":"Cedars-Sinai Medical Center","ror":"https://ror.org/02pammg90","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1282927834"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Durie","raw_affiliation_strings":["Cedar Sinai Medical Center, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cedar Sinai Medical Center, Los Angeles","institution_ids":["https://openalex.org/I1282927834"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066940168","display_name":"S. Vincent Rajkumar","orcid":"https://orcid.org/0000-0002-5862-1833","observed_orcids":["https://orcid.org/0000-0002-5862-1833"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. V. Rajkumar","raw_affiliation_strings":["Mayo Clinic, Rochester MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Richardson","raw_affiliation_strings":["Dana Farber Cancer Institute, Boston MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana Farber Cancer Institute, Boston MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038235561","display_name":"Robert Zygmunt Orlowski","orcid":"https://orcid.org/0000-0002-5723-4129","observed_orcids":["https://orcid.org/0000-0002-5723-4129"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Orlowski","raw_affiliation_strings":["MD Anderson Cancer Center, Houston TX, United States of America"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston TX, United States of America","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":16,"corresponding_author_ids":["https://openalex.org/A5009378735"],"corresponding_institution_ids":["https://openalex.org/I1334819555"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.10487528,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"855","last_page":"856"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-risk-multiple-myeloma","display_name":"high-risk myeloma","score":0.9020000100135803},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9300000071525574},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/elotuzumab","display_name":"elotuzumab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7099999785423279},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9739999771118164},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7440000176429749},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.7179999947547913},{"id":"https://openalex.org/keywords/1q21-amplification","display_name":"1q21 amplification","score":0.718999981880188},{"id":"https://openalex.org/keywords/17p-deletion","display_name":"17p deletion","score":0.9300000071525574},{"id":"https://openalex.org/keywords/gene-expression-profiling","display_name":"gene expression profiling","score":0.6129999756813049},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.6809999942779541},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4690000116825104},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.5929999947547913},{"id":"https://openalex.org/keywords/immunomodulators","display_name":"immunomodulators","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.8766200542449951},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.7913782000541687},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.7490538358688354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6945531964302063},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6906801462173462},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6762412190437317},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.5917734503746033},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5359601974487305},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.521510899066925},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.4831477999687195},{"id":"https://openalex.org/C2780401358","wikidata":"https://www.wikidata.org/wiki/Q422252","display_name":"Dexamethasone","level":2,"score":0.447297602891922},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4260568916797638},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4147632122039795},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39060884714126587},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3577708601951599},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.31308478116989136},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.27729082107543945},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.18319958448410034}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000846728.05693.f8","doi":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9430248","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/9430248","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:c2f21220f24849ceb2ed8389d8158765","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/c2f21220f24849ceb2ed8389d8158765","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 855-856 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000846728.05693.f8","doi":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000846728.05693.f8","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.5799999833106995,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3031387218","https://openalex.org/W1996748901","https://openalex.org/W2008433270","https://openalex.org/W2982687159","https://openalex.org/W2340942222","https://openalex.org/W2307739936","https://openalex.org/W2140486815","https://openalex.org/W2900140485","https://openalex.org/W2059095707","https://openalex.org/W4295828468"],"abstract_inverted_index":{"Background:":[0],"The":[1,414,441],"introduction":[2],"of":[3,78,115,157,219,374,391,448],"immunomodulatory":[4],"agents,":[5],"proteasome":[6],"inhibitors,":[7],"and":[8,81,173,209,379,385,416,422,443,456],"autologous":[9],"stem":[10],"cell":[11,99,130],"transplantation":[12],"(ASCT)":[13],"has":[14],"improved":[15],"outcomes":[16,39],"for":[17,398,419,434,460,465],"patients":[18,282,323],"with":[19,25,93,283,324,387],"multiple":[20],"myeloma":[21],"(MM),":[22],"but":[23,103],"those":[24],"high":[26],"risk":[27],"MM":[28],"(HRMM)":[29],"have":[30],"a":[31,70,147,153,388],"poor":[32],"long-term":[33],"prognosis.":[34],"Herein":[35],"we":[36],"provide":[37],"survival":[38,57],"on":[40,52,401],"the":[41,53,116,143,179,276,364,372,395,425,449,452,458],"first":[42,365],"randomized":[43,71,366],"trial":[44,74],"in":[45,225,244,275,424,445],"newly":[46],"diagnosed":[47],"HRMM,":[48],"S1211,":[49],"to":[50,370,376],"follow-up":[51,218,390],"previously":[54],"reported":[55,369],"progression-free":[56],"(PFS)":[58],"(NCT01668719,":[59],"Usmani":[60],"SZ":[61],"et":[62],"al,":[63],"Lancet":[64],"Haem":[65],"2021).":[66],"Aims:":[67],"S1211":[68,184],"is":[69,404],"phase":[72],"II":[73],"comparing":[75],"8":[76],"cycles":[77],"lenalidomide,":[79],"bortezomib":[80],"dexamethasone":[82],"(RVd)":[83],"induction":[84,378],"followed":[85],"by":[86,113],"dose-attenuated":[87],"RVd":[88,189,377,426],"maintenance":[89,380],"until":[90,107],"disease":[91],"progression":[92],"or":[94,133],"without":[95],"elotuzumab":[96],"(RVd-Elo).":[97],"Stem":[98],"collection":[100],"was":[101,105,111,142,176,228,246,288,304,328,345],"allowed,":[102],"ASCT":[104],"deferred":[106],"progression.":[108],"Methods:":[109],"HRMM":[110,367,438],"defined":[112],"one":[114],"following:":[117],"gene":[118],"expression":[119],"profiling":[120],"high-risk":[121],"(GEPhi),":[122],"t(14;16),":[123,202],"t(14;20),":[124],"del(17p),":[125,200,325],"amplification":[126],"1q21,":[127,285],"primary":[128,144],"plasma":[129],"leukemia":[131],"(pPCL),":[132],"elevated":[134,211],"serum":[135],"LDH":[136,212],"(\u2265":[137],"2X":[138],"ULN).":[139],"Median":[140],"PFS":[141,227,287,327,384,397,415,442],"endpoint,":[145],"using":[146,178],"one-sided":[148,154],"stratified":[149],"log-rank":[150],"test":[151],"at":[152],"significance":[155],"level":[156],"0.1.":[158],"Secondary":[159],"endpoints":[160],"included":[161],"overall":[162],"response":[163],"rate":[164],"(ORR),":[165],"adverse":[166,170],"events":[167,171],"(AE),":[168],"serious":[169],"(SAE)":[172],"OS.":[174],"Response":[175],"assessed":[177],"IMWG":[180],"2009":[181],"criteria.":[182],"Results:":[183],"enrolled":[185],"103":[186],"evaluable":[187],"patients,":[188],"n=54,":[190],"RVd-Elo":[191,402],"n=49.":[192],"74%":[193],"had":[194,269],"ISS":[195],"II/III,":[196],"48%":[197],"amp1q21,":[198],"38%":[199],"11%":[201],"9%":[203],"GEPhi,":[204],"7%":[205],"pPCL,":[206],"5%":[207],"t(14;20)":[208],"4%":[210],"(17%":[213],"\u22651":[214],"feature).":[215],"With":[216],"median":[217,226,250,286,302,326,343,389,396],"72":[220,350],"months":[221],"(mos.),":[222],"no":[223,273],"difference":[224,243],"observed":[229,247,329,418],"[RVd-Elo=29":[230],"mos.,":[231,234,256,290,293,308,311,331,334,351],"RVd=":[232,254,291,309,332,349],"34":[233],"HR":[235,257,294,312,335,352],"=":[236,249,258,265,295,306,313,320,336,347,353,360],"1.11":[237],"(80%":[238,260,297,315,338,355],"CI=0.82,":[239],"1.49,":[240],"p=0.66].":[241],"No":[242],"OS":[245,303,344,386,417,444],"[RVd-Elo":[248,305,346],"not":[251,382,410],"reached":[252],"(NR),":[253],"68":[255,310],"0.85":[259],"CI:":[261,316,356],"0.59,":[262],"1.23),":[263],"p-value":[264,319,359],"0.58].":[266],"76%":[267],"pts":[268],"\u2265Grade":[270],"3":[271],"AEs,":[272],"differences":[274],"safety":[277],"profile":[278],"were":[279],"observed.":[280],"Amongst":[281],"gain/amp":[284,420],"[RVd-Elo=31":[289],"37":[292],"1.48":[296],"CI=":[298,339],"0.95,":[299],"2.31),":[300],"p=0.25],":[301],"61":[307],"1.23":[314],"0.72,":[317],"2.10),":[318],"0.63].":[321],"In":[322,363],"[RVd-Elo=41":[330],"30":[333],"0.98":[337],"0.60,":[340],"1.58),":[341],"p=0.95],":[342],"NR,":[348],"0.77":[354],"0.40,":[357],"1.48),":[358],"0.61].":[361],"Summary/Conclusion:":[362],"study":[368,450],"date,":[371],"addition":[373],"Elo":[375],"did":[381,409],"improve":[383],"6":[392],"years.":[393],"Although":[394],"Del17p":[399],"subgroup":[400],"arm":[403,428],"higher":[405],"than":[406],"RVd,":[407],"it":[408],"achieve":[411],"statistical":[412,454],"significance.":[413],"1q21":[421],"del17p":[423],"control":[427],"may":[429],"serve":[430],"as":[431],"important":[432],"benchmarks":[433],"future":[435],"enrichment":[436],"design":[437],"clinical":[439],"trials.":[440],"both":[446],"arms":[447],"exceeded":[451],"original":[453],"assumptions":[455],"support":[457],"role":[459],"PI/IMiD":[461],"combination":[462],"induction/maintenance":[463],"therapy":[464],"this":[466],"population.":[467]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2025-10-10T00:00:00"}